Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia

  • Post author:
  • Post published:October 7, 2026
  • Post category:

Critical limb ischemia (CLI) represents a significant unmet medical need without any approved medical therapies for patients who fail surgical or angioplasty procedures to restore blood flow to the lower…

Continue ReadingPhase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia

MSC engineered to produce BDNF for the treatment of Huntington’s disease

  • Post author:
  • Post published:October 7, 2026
  • Post category:

One in every ten thousand people in the USA has Huntington's disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingMSC engineered to produce BDNF for the treatment of Huntington’s disease

Human ES cell based therapy of heart failure without allogenic immune rejection

  • Post author:
  • Post published:October 7, 2026
  • Post category:

Heart failure is a major and ever-growing health problem affecting an estimated 5.8 million Americans with about half a million new cases every year. There are limited therapeutic options for…

Continue ReadingHuman ES cell based therapy of heart failure without allogenic immune rejection

Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

  • Post author:
  • Post published:October 7, 2026
  • Post category:

Alzheimer disease (AD), the most common cause of dementia among the elderly and the third leading cause of death, presently afflicts over 5 million people in the USA, including over…

Continue ReadingNeural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

  • Post author:
  • Post published:October 7, 2026
  • Post category:

One in every ten thousand people in the USA have Huntington's Disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingSustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders
  • Go to the previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us